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Abstract
Background: Hydnora abyssinica (HA) A. Braun is an endemic Sudanese medicinal plant traditionally used as
anti-inflammatory and against many infectious diseases. However, it proved to be very rich in phenols and
tannins, so the present study was undertaken to investigate the immunomodulatory potential of the whole
plant ethanolic extract and its isolated compounds.
Methods: Lymphocyte proliferation, chemiluminescence and superoxide reduction assays were used for
immunomodulatory evaluation. While, MTT (3–(4, 5-dimethylthazol-2-yl)-2, 5-diphenyl tetrazonium bromide)
test was performed on 3 T3 cell line clone in order to evaluate the cytoxicity effect of the extracts and isolated
compounds of phenolic derivatives which were carried out by chromotographic techniques.
Results: Catechin, (1), tyrosol (2) and benzoic acid, 3, 4, dihydroxy-, ethyl ester (3) compounds were isolated
from HA ethanolic extract which revealed potent immunosuppressive activity against reactive oxygen species
from both polymorph nuclear cells (PMNs) (45–90 % inhibition) and mononuclear cells (MNCs) (30 -65 % inhibition),
T lymphocyte proliferation assay (70–93 % inhibition) as well as potent inhibitory effect against superoxide production
(42–71 % inhibition) at concentrations of 6.25–100 μg/mL. Catechin (1) was found the most potent immunosuppressive
agent among all constituents examined.
Conclusion: These results can support the traditional uses of H. abyssinica extracts as anti-inflammatory and
immunosuppressive and further investigations of the mode of action and other pharmacological studies are
highly desirable.
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Background
Immunosuppressive drugs are commonly prescribed to
prevent the rejection of transplanted organs, or to treat
chronic inflammatory diseases, such as ulcerative colitis,
neutropenia, Crohn’s disease, rheumatoid arthritis and
connective tissue disorders [1–3].
From centuries people has been using the herbal medi-
cines for the treatment of various diseases [4, 5]. Up
today, ethnomedicine still plays the axial role in the
search and development of new drugs [6]. Similarly for
many developing countries, herbal drugs have a major
importance based on indigenous knowledge, cultural
acceptability and affordability [7]. Indeed, it is estimated
that about 90 % of Sudanese population depend mainly
on herbal medicines for the primary treatment of vari-
ous types of diseases, ranging from simple disorders to
more chronic pathologies such as cancers [8].
H. abyssinica belongs to the family Hydronaceae (Leaf-
less and rootless parasite). The plant is locally known as
“Tartous”, and distributed in central Sudan. In Sudanese
folk medicine, the whole plant aqueous extract is used
for the treatment of swellings, tonsillitis and dysentery
[9]. The plant aqueous extract had shown considerable
molluscicidal activities against Bulinus truncatus and
Biomphalaria pfeifferi [10]. Recently preliminary phyto-
chemical analysis of H. abyssinica has shown the latter
to be very rich in phenols and tannins [11].
In spite of its ethnobotanical uses, there is a paucity of
pharmacological and chemical data on Sudanese tartous.
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To this effect, the present study was therefore under-
taken to investigate the immunomodulatory activity of
the whole plant ethanolic extract and its isolated second-
ary compounds through lymphocyte proliferation, che-
milumenscence and superoxide reduction assays. MTT
cytotoxicity against 3 T3 cell line carried out for plant
ethanolic extracts and the isolated compounds.
Methods
Plant material
The selected plant species was collected from its natural
habitat in the central Sudan around Acacia sp. Voucher
specimens was identified by Dr. Wai’l S. Abdalla and Mr.
Haidar Elsidig of Herbarium of Medicinal and Aromatic
Plants Research Institute (MAPRI), Khartoum, Sudan,
where the specimen was also deposited (MO22–07).
Preparation of the crude extract
Hundred grams of whole plant material was air-dried
under the shed, grounded, and extracted by triple soak-
ing in 80 % ethanol at room temperature for 3 days. Ex-
tracts were obtained by removing the organic solvent
under reduced pressures by using rotary evaporator.
Isolation of secondary metabolites (constituents)
Spectroscopic techniques
UV Spectra were recorded in methanol or chloroform
on a Hitachi UV 3200 spectrophotometer. IR Spectra
were recorded in CHCl3 or KBr on a Jasco A-302 IR
spectrophotometer. The EI MS spectra were recorded
on a double focusing mass spectrometer (Varian MAT
311A). HREI MS measurements were performed on a
Jeol HX 110 mass spectrometer. The 1H-NMR spectra
were recorded on Bruker AC-300 and AM-400 MHz in-
struments, while 13C-NMR spectra were recorded at 100
and 125 MHz. Multiplicities of the carbon signals were
determined by DEPT 90° and 135° experiments. 1H-
NMR and 13C-NMR chemical shifts were reported in δ
(ppm) and coupling constants (J) were measured in Hz.
Chromatographic techniques
Column chromatography was performed on A silica gel
60 (70–230 and 240–300 mesh sizes, E. Merck), Diaion
HP-20 Resin and Sephadex LH-20 were used. Final puri-
fication of some compounds was achieved by preparative
recycling HPLC (model LC-908) (JAI) and the columns
used were L-80 or H-80 (YMC, Co. Ltd) at appropriate
flow rates (4 mL/min) using equivalent combinations
of MeOH and H2O. Pre-coated silica gel TLC plates
(E. Merck, F254) were used for evaluating the com-
pounds. TLC plates were viewed under ultraviolet
light at 254 nm for fluorescence quenching spots and
at 366 nm for fluorescent spots. Ceric-sulphate in
10 % H2SO4 spraying reagent was used for staining the
compounds on TLC.
Isolation and purification of compounds
Dried powder of the whole plant (3 Kg) was extracted
exhaustively with 80 % ethanol at room temperature.
The filtrate was evaporated under vacuum reduced pres-
sure to yield (1.2 Kg). The residue was suspended in
distilled water (partially soluble) then partitioned in differ-
ent solvents on the basis of increasing polarity (solvent
solvent system of fractionation or liquid-liquid extraction)
using big size separating funnel (5 L) to get n-hexane
(0.2 g), chloroform (0.5 g), ethyl acetate (14 g) and n-butanol
(60 g), (Fig. 1)
The crude ethyl acetate fraction (14 g) was subjected
to column chromatography eluted with 50 % chloro-
form/n-hexane with gradient increase of chloroform up
to 100 and methanol up to 100 %. Ten fractions were
obtained. On repeated flash column chromatography
using chloroform/methanol system for fraction (8), com-
pound 1 was obtained by elution column with 15 %
methanol/chloroform.
Fractions 4 and 5 were loaded on reverse phase Sephadex
column LH-20 starting by high polarity 100 % distilled
water and followed by a gradient decrease with methanol
until 100 % methanol, from each fraction 3 sub fractions
were obtained, the sub fraction (2) of each were subjected
to recycling preparative high performance liquid chroma-
tography (HPLC), using mobile phase of water-methanol
(1:1) on L-80 ODS column (reverse phase). The purification
of compounds 2 and 3 was conducted by using repeated
recycling HPLC.
Bioassay techniques
Isolation of Human Polymorphoneutrophils (PMNs) and
Mononuclear Cells (MNCs)
Heparinized blood was obtained by vein puncture asep-
tically from healthy volunteers (25–38 years age). The
consent was obtained from the healthy donors for the
use of their blood in this study. The buffy coat contain-
ing PMNs and MNCs was collected by dextran sedimen-
tation and the cells were isolated after the Lymphocyte
Separation Medium (LSM) density gradient centrifuga-
tion. MNCs were separated gently by collecting them
from the plasma- ficoll interface using pasteur pipette,
while PMNs were collected from the tube base. Cells
were washed twice and suspended in Hank’s Balance Salt
Solution [Ca and Mg free] (HBSS−−), pH 7.4. Neutro-
phils were purified from RBCs contamination using
hypotonic solution. Cells were adjusted to their required
concentration using Hank’s Balance Salt Solution con-
taining Ca and Mg (HBSS++). The study was approved
by the local Ethics Committee (MAPRI Ethics Committee,
National Centre for Research, Khartoum, Sudan).
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Chemiluminescence assay
Luminol or lucigenin–enhanced chemiluminescence
assay were performed as described by Helfand et al.
[12] and Haklar et al. [13]. Briefly, 25 μL of PMNCs
(1 × 106) and MNCs (5 × 106) cells were incubated with
25 μL of serially diluted plant extract with concentra-
tion ranges between 6.25 to 100 μg/mL. while concen-
trations of 3.13 to 50 μg/mL were used for pure
compounds. Predinsalone was used as reference drug
(control positive) with concentration of 10 μg/mL.
Control wells (control negative) received HBSS++ and
cells but no extract. Tests were performed in white 96
wells plates in triplicate for each concentration and
controls, which were incubated at 37 ° C for 30 min in
the thermostated chamber of the luminometer. Op-
sonized zymosan-A or PMA 25 μL, followed by 25 μL
luminol (7 × 10−5M) or lucigenin (0.5 mM) along with
HBSS++ was added to each well to obtain a 200 μL
volume/well. The luminometer results were monitored
as chemiluminescence RLU (relative light unit), with
peak and total integral values set with repeated scans
at 30 s intervals and one second points measuring
time.
T-cell proliferation assay
Cell proliferation was evaluated by standard thymidine
incorporation assay following a method reported by
Nielsen et al. [14]. Briefly, cells were obtained from per-
ipheral blood of healthy individuals (the consent was
obtained from the healthy donors for the use of their
blood in this study which was approved by the local
Ethics Committee (MAPRI Ethics Committee, National
Centre for Research, Khartoum, Sudan). Then cultured
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Fig. 1 Isolation of secondary metabolites from H. abyssinica
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bottom tissue culture plates (Nalge Nunc. Inter. USA).
Preliminary experiments were conducted to determine
the optimum concentration of PHA on T-cell prolifera-
tion. PHA concentration 5 μg/mL was found to be
optimum and used in our experiment. Cells were stim-
ulated with 5 μg/mL of PHA (Sigma-Aldrich Co.,
USA). Various concentrations of plant extracts were
added to obtain final concentrations of 6.25, 12.5, 25,
50 and 100 μg/mL, each in triplicate. In another set of
experiment cells were incubated with half concentra-
tions of compounds and predinsalone was used as ref-
erence drug (control positive) with concentration of
10 μg/mL. After 24 h, cells were washed twice and then
stimulated with 5 μg/mL PHA. The plates were incu-
bated for 72 h at 37 °C in 5 % CO2 incubator. After
72 h, cultures were pulsed with (0.5 μCi/well) [H3] triti-
ated thymidine (Amersham Pharmacia Biotech, USA),
and further incubated for 18 h. Cells were harvested
onto a glass fiber filter (Cambridge Technology, USA)
using cell harvester (SKATRON A.S. Flow Lab.,
Norway). The tritiated thymidine incorporated into the
cells was measured by a liquid scintillation counter (LS
6500, Beckman Coulter, USA). Results were expressed
as mean count per minute (CPM). The inhibitory activ-
ity of T lymphocyte proliferation was calculated using
the following formula:
Inhibitory activity %ð Þ ¼
100 x
Control group CPMð Þ−Experiment group CPMð Þ
Control group CPMð Þ
Superoxide anion radical scavenging activity
The experiment was carried out in 96 microtiter ELISA
plates with complete volume of 200 μL/ well. 10 μL of
tested samples were dissolved in DMSO (final concen-
tration of 1 mM for pure compounds and the above
mentioned 5 concentrations for the plant extract) in
this experiment. For the generation of the superoxide
radicals 90 μL of phosphate buffer (0.1 M, pH 7.5) were
added, followed by the addition of 40 μL (80 mM) of
NBT (nitroblue tetrazolium) solution and 40 μL (280 mM)
NADH (nicotinamide adenine dinucleotide hydrogen
reduced form) and the reaction was started by adding
20 μL (8 mM) of PMS (phenazine methosulphate) so-
lution to the mixture. The reaction mixture was incu-
bated at 25 °C for 5 min and the absorbance at
560 nm was measured against blank samples. Propyl
gallate was used as a positive control and DMSO as
negative control. Decreased absorbance of the reaction
mixture indicated increased superoxide anion scaven-
ging activity. The inhibition percentage of superoxide




Control group ODð Þ−Experiment group ODð Þ
Control group ODð Þ
MTT cytotoxicity test
Serial dilutions of compound was prepared in a 96-well flat
bottomed plate (Nalge Nunc, Inter. USA). The outer wells
of the plate were filled with 250 μL of in-complete culture
medium, except the last row 6 middle wells (B - G), which
were used for the negative control receiving 50 μL of cul-
ture medium and 2 μL of sterile 0.5 % Triton X.
To the rest of the plate, 50 μL/wells (CCM) were
added and 30 μL more were added to second column
wells (B – G) that were used as first compounds dilution
wells. To the first dilution wells in the row, 20 μg of
compound suspension were added to the 80 μL. Com-
pounds were then serially diluted by two-fold dilution
from well B3 till B11 by transferring 50 μL to the next
well after proper mixing. From the last dilution wells
(B-11), 50 μL were discarded. Each compound was tested
in triplicate. Cell suspension in a complete culture medium
containing 2.5 × 105/mLwas properly mixed, and 150 μL of
it were transferred into each well of the plate. The plate
was covered and placed in 5 % CO2 incubator at 37 °C for
three-five days (72–120 h). On the third/fifth day, the
supernatant was removed from each well without detach-
ing cells. MTT stock (5 mg/mL) was prepared earlier in
100 mL PBS. MTT suspension was vortexed and kept on
magnetic stirrer until all MTT dissolved. The clear suspen-
sion was filter sterilized with 0.2 μm Millipore filter and
stored at 4 °C or –20 until use. MTT was diluted in a cul-
ture medium (1:3.5) and brought to room temperature. To
each well of the 96-well plates, 50 μL of diluted MTT were
added. The plate was incubated further at 37 ° C for 2 to
3 h in CO2 incubator. MTT was removed carefully without
detaching cells, and 200 μL of DMSO were added to each
well. The plate was agitated at room temperature for
15 min then read at 540 nm using microplate reader.
Statistical analysis
All data are presented as means ± standard deviation of
the mean. Statistical analysis for all the assays results
were done using student’s t-test. Significance was attrib-





It is a well known polyphenolic secondary metabolite,
isolated for the first time from H. abyssinica, ethyl
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acetate (bulk amount 2 g) fraction by using 25 mm
diameter column chromatography (silica gel) in chloro-
form methanol system, purified from sub fraction col-
umn 8 in 50 % ethyl acetate/chloroform.
Physical status: White crystals
Yield: 6.7 X 10−2%
Rf: 0.7 (15 % Chloroform/methanol)
Melting point: 241–243 °C.
[α]D
25:−45 °(c = 0.1, CH3OH)
IR (KBr) νmax cm
−1: 3420 (OH), 1646 (C = C).
1H NMR (CD3OD, 300 MHz, δ): 6.83 (1H, d J =
1.7 Hz, H-2′), 6.75 (1H, d J = 8.1 Hz, H-5′), 6.72 (1H,
d J = 1.8 Hz, H-6′), 5.9 (1H, d J = 2.2 Hz, H-8), 5.8
(1H, d J = 2.2 Hz, H-6), 4.55 (1H, d J = 7.5 Hz, H-2),
3.98 (1H, dt, J = 7.6 Hz, J = 5.3 Hz H-3), 2.87 (2H, dd,
J = 5.5,10.7 Hz H-4).
13C NMR (CD3OD, 100 MHz, δ): 157.5 (C-7), 157.3
(C-5), 156.0 (C-9), 146.2 (C-3′ and 4′), 132.2 (C-1′),
120.0 (C-6′), 116.3 (C-2′), 100.8 (C-10), 96.3 (C-6),
95.5 (C-8), 82.2 (C-2), 68.8 (C-3), 28.5 (C-4)
HREI MS: m/z 290.272 (calcd 290.0790 for
C15H14O6)
EI MS (rel.int. %): m/z 290 (16), 167 (3), 152 (44), 139
(100), 124 (17), 110 (9), 77 (14), 69 (26).
2-(4 hydroxyphenyl) ethanol (Tyrosol) (2)
It is a simple phenol derivative compound isolated from
H. abyssinica ethyl acetate fraction by using recycling P-
HPLC (1:1) water: methanol L-80 ODS reversed phase
column.
Physical status: Colorless needles
Yield: 2.7 X 10−4%
Rf: 4.7 (10 % chloroform/methanol)
Melting point: 85–86 °C.
IR (CH3OH) νmax cm
−1: 3380, 3140 (OH), 1590 (C =C)
1H NMR (CD3OD, 400 MHz, δ): 7.0 (1H, d, J = 2.1 Hz,
H-2 and 6), 6.7 (1H, m, H-3 and H-5), 3.6 (2H, t, J =
7.2 Hz, H-8), 2.7 (2H t, J = 7.2 Hz, H-7).
13C NMR (CD3OD, 100 MHz, δ): 159.2 (C-4),
131.3 (C-1), 130.8 (C-3 and 5), 116.1 (C-2 and C-6),
64.0 (C-8), 40.0 (C-7).
HREI MS: m/z 138.66 (calcd 138.0681 for C8H10O2)
EI MS (rel.int. %): m/z 138 (39), 121 (32), 107 (100),
93 (8), 77 (44).
Benzoic acid, 3, 4, dihydroxy- ethyl ester (3)
It is benzoic acid and phenol derivative, isolated from H.
abyssinica ethyl acetate fraction by using recycling
P-HPLC (1:1) water: methanol L-80 ODS reversed
phase column.
Physical status: Colorless crystal
Yield: 3.4 X 10−4%
Rf: 6.5 (10 % chloroform/methanol)
Melting point: 130–135 °C.
IR (KBr) νmax cm
−1: 3660 (OH), 1765 (C = O), 1587
(C = C), 1250 (C-O)
1HNMR (CD3OD, 400 MHz, δ): 7.4 (1H, dd, J =
8.8 Hz, J = 1.0 Hz, H-5), 6.7 (1H, d, J = 8.0 Hz, H-2), 4.3
(2H, m, H-8), 1.3 (3H, m, Me-9).
13C NMR (CD3OD, 100 MHz, δ): 168.4 (C-7),
151.8 (C-1), 146.2 (C-6), 123.5 (C-3), 122.8 (C-4),
117.4 (C-2),115.8 (C-5), 61.6 (C-8), 14.7 (C-9).
HREI MS: m/z 182.176 (calcd 182.0579 for C8H10O2)
EI MS (rel.int. %): m/z 182 (35), 153 (17), 137 (100),
109 (45), 77 (52).
Chemiluminescence assay
The preliminary screening results of H. abyssinica
ethanolic extract on both isolated immune cells
types,PMNs and MNCs was carried out after activa-
tion of cells using serum opsonized zymosan (SOZ)
Koko et al. BMC Complementary and Alternative Medicine  (2015) 15:400 Page 5 of 9
and followed by luminol as indicator. The dose
dependent inhibitory properties for phagocytosis was
reported for all tested concentrations (6.25 to 100 μg/mL)
against both PMNs (45–90 % inhibition) and MNCs
(30–65 % inhibition) Fig. 2. The inhibitory effects of
the isolated compounds on PMNs activated by SOZ
was found 92, 79 and 95 % with higher concentra-
tion {50 μg/mL} and 30, 25 and 5 % with the lower
concentration {3.15 μg/mL} for the compounds cat-
echin (0.17–0.01 mM), tyrosol (0.36–0.02 mM) and
benzoic acid derivative (0.27–0.02 mM), respectively
Fig. 3.
T-cell proliferation assay
The effects of H. abyssinica extract and isolated com-
pounds on 3H-thymidine incorporation into PHA
(phytohaemagglutinin)-stimulated peripheral blood
mononuclear cells are presented in Figs. 4 and 5. In-
hibitory % of T-cell proliferation for H. abyssinica etha-
nolic extract was found in the range 67-97 % for the
tested concentrations 6.25–100 μg/mL. The inhibitory
% of isolated compounds was found in the range of 83–98,
71–95 and 66–94 % for the tested concentrations
(3.15–50 μg/mL) of catechin, tyrosol and benzoic acid
derivative, respectively.














Fig. 3 Inhibitory properties of isolated phenolic compounds for PMNs activated by SOZ (luminol based)
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Superoxide anion radical scavenging activity
The plant ethanolic extract was screened for its superoxide
radicals scavenging by using 5 concentrations (6.25 –
100 μg/mL). These concentrations had shown inhibitory
activity for superoxide production ranging from 42 to 72 %
inhibition (Fig. 6). While the isolated compounds revealed
87, 83 and 82 % inhibition for catechin, tyrosol and benzoic
acid derivative respectively (Fig. 6).
MTT cytotoxicity test
Neither the plant ethanolic extract nor isolated com-
pounds revealed cytotoxic activity against 3 T3 cell line
(Table 1).
Discussion
Since immemorial time plants have been used as an al-
ternative therapy and has stood the test of time. Indeed,
many medicinal plants are traditionally used to control
unregulated immune stimulation in the cases of anaphyl-
actic shock [15], inflammatory response, asthma, etc.
[16, 17].
During the present investigation, the ethanolic extract
of H. abyssinica whole plant showed a significant sup-
pression towards the immune response activation which
was assayed by oxidative burst chemiluminescence for
both polymorph nuclear cells (PMNs) (45–90 % inhib-
ition) and mononuclear cells (MNCs) (30–65 %
Fig. 4 Inhibitory properties of H. abyssinica ethanolic extract for T lymphocyte proliferation the cells were stimulated with PHA
Fig. 5 Inhibitory properties of isolated phenolic compounds for T lymphocyte proliferation the cells were stimulated with PHA
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inhibition) activated with SOZ. However, in the second
assay, T- cell proliferation activity was inhibited signifi-
cantly (67–97 % inhibition) with all tested concentra-
tions (6.25–100 μg/mL). Also these concentrations were
found to be of a significant inhibition for superoxide free
radicals (42 to 72 % inhibition). Superoxide radicals
scavenging assay was conducted to evaluate immunsu-
pressive activity due the fact that all reactive oxygen spe-
cies play a major role in the long-term complications of
immune-related diseases [18, 19]. However, in the
present work, SOZ was used for the stimulation phago-
cytic cells for superoxide and others reactive oxygen spe-
cies production. Luminol is characterized by its ability to
enter the cell and reacts with intracellular reactive
oxygen species (ROS) [20, 21].
The above study on H. abyssinica ethanolic extract en-
courage further investigation on the plant for the isolation
of secondary metabolites, responsible of these activities.
Interestingly, these three well known phenolic compounds
were isolated for the first time from H. abyssinica. All of
these compounds showed suppression of oxidative burst
(79–95 % inhibition) for the highest concentration 50 μg/
mL and 5–30 % inhibition for the lowest concentration
(3.2 μg/mL). All of them revealed potent inhibition for
T-cell proliferation (94–98 % inhibition) for the highest
concentration (50 μg/mL) and (66–83 % inhibition) for
the lowest concentration (3.2 μg/mL). Also they showed
inhibition for superoxide production (82–87 %). Results
reported from the present study are consistent and in
line with the previous observation of Wang et al. [22].
They indicated that aromatic compounds are extremely
active in suppressing immune responses in both in-
vitro and in-vivo.
Catechin (1) was found the most potent immunosup-
pressive, among all the compounds tested. Previous
studies indicated that catechin is the major polyphenol
component of green tea, which has attracted a consider-
able attention during the last years. It is a powerful anti-
oxidant and the significant activities against all diseases
are found associated with ROS productions [23, 24].
Neither H. abyssinica extract nor isolated compounds
possesed cytotoxicity activity against 3 T3 cell line.
Fig. 6 Inhibitory properties of H. abyssinica ethanolic extract and isolated compounds for superoxide production
Table 1 MTT reduction cytotoxic assay for evaluation of H. abyssinica and its isolated compounds for their inhibition % against 3T3
cell line
Conc. in μg/mL Compound (1) Compound (2) Compound (3) Ethanolic extract
50 17.8 + 3.3 17.2 + 3.7 15.8 + 5.1 12.4 + 4.2
25 14.4 + 4.1 14.2 + 2.8 12.5 + 4.3 11.5 + 3.5
12.5 10.8 + 3.6 12.1 + 3.1 11.4 + 4.1 10.2 + 2.7
6.25 8.1 + 2.8 4.0 + 1.3 11.9 + 3.8 8.7 + 2.3
3.13 1.4 + 0.3 3.4 + 0.4 4.7 + 1.1 -
Triton X 66.7 + 11.6
This table indicates the activity of HA ethanolic extract and isolated compounds on the viability of 3T3 cell line after 72 h incubation with and without five
concentrations (6.25–100 μg/mL) of the plant extract and (3.13–50 μg/mL) for isolated compounds. Triton X 0.5 % was used as control positive. Cells viability was
evaluated by MTT reduction to the blue colored formazan in living cells which was detected by measuring absorbance at 540 nm against blank samples. The %
inhibition was calculated as: % Inhibition = [(AControl − ASample)/AControl] × 100
Where AControl is the absorbance of the negative control and ASample the absorbance of tested samples or standard. Readings are presented in mean ± SD of
three repeats
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Although they were revealed dose dependant cytotoxic
effect but the maximum examined concentration was
found of less than 20 % and the IC50 going to be more
than 10000 μg/mL, which is 200 times the higher con-
centrations examined.
Conclusion
In our conclusion we can support the traditional uses of
H. abyssinica extracts as anti-inflammatory and im-
munosuppressive, mainly due to the dominant quantities
of catechin (>0.07 %) and other phenolic compounds.
Further investigations of the mode of action and other
pharmacological studies such like the level of various cy-
tokines in the peripheral blood that is possible to suggest
for understand of immune response activity also more
experimental analysis for the characterization of immune
response activity by the catechin are highly desirable.
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